Antibiotic

Myxothiazol is an antifungal antibiotic that acts as an inhibitor of mitochondrial electron transport chain complex III (bc1 complex). It demonstrates potent antifungal activity against various yeasts and fungi, exhibiting effective growth inhibition at concentrations ranging from 0.01 to 3 μg/ml. This compound is valuable for research applications focused on mitochondrial function and the mechanisms of antifungal resistance.

Siomycin A is a thiopeptide antibiotic that selectively inhibits Forkhead box M1 (FOXM1), while sparing other Forkhead box family members. It exhibits significant anti-tumor activity and promotes apoptosis, making it a valuable tool for cancer research. This compound is particularly useful for studies focused on the role of FOXM1 in tumorigenesis and therapeutic resistance.

Bleomycin A5 (hydrochloride) is a glycopeptide antibiotic that primarily functions as a DNA inhibitor. This compound exerts its cytotoxic effects by chelating Fe2+, which leads to the formation of reactive species that induce both single-strand and double-strand breaks in DNA, thereby disrupting DNA replication. Additionally, Bleomycin A5 (hydrochloride) inhibits Drp1-mediated mitochondrial fission and modulates the PINK1/Parkin pathway, contributing to mitochondria-mediated apoptosis. It is widely utilized in cancer research applications.

Actinonin is a naturally occurring antibiotic that functions primarily as an aminopeptidase N inhibitor. It exhibits potent antimicrobial activity and acts as a reversible peptide deformylase (PDF) inhibitor with a Ki value of 0.28 nM. Additionally, Actinonin shows inhibitory effects on matrix metalloproteinases MMP-1, MMP-3, MMP-8, and MMP-9, with respective Ki values of 300 nM, 1,700 nM, 190 nM, and 330 nM. It also possesses pro-apoptotic properties and has demonstrated antiproliferative and antitumor activities, making it a valuable tool for cancer research and therapeutic exploration.

RK-286D is a potent antibiotic and selective protein kinase C (PKC) inhibitor that exhibits significant antimicrobial properties. This compound effectively inhibits bleb formation induced by phorbol 12,13-dibutyrate (PDBu) and demonstrates notable activity in vitro against PKC. RK-286D is suitable for research applications exploring microbial resistance and PKC-related cellular signaling pathways.

Pyridomycin is a selective inhibitor of InhA, an essential enzyme in Mycobacterium tuberculosis, providing a targeted approach in combating this pathogen. As an antibiotic derived from the metabolites of Dactylosporangium fulvum, Pyridomycin exhibits low cytotoxicity while effectively impeding the growth of Mycobacterium tuberculosis. Its application is significant in the study and treatment of bacterial infections, particularly tuberculosis, making it a valuable reagent for research in infectious disease mechanisms and antibiotic development.

Levorin A0 is an aromatic polyene antibiotic known for its potent antifungal properties. It primarily acts by disrupting the integrity of fungal cell membranes, leading to cell death. This compound is essential for research focused on antifungal drug development and understanding membrane-targeting mechanisms in fungal pathogens. Its efficacy against a range of fungi makes it a valuable tool in both in vitro and in vivo studies.

Neplanocin A is an antitumor antibiotic that functions as an irreversible inhibitor of AdoHcy hydrolase, with a Ki of 8.39 nM. It exhibits significant antitumor activity against murine L1210 leukemia cells and also demonstrates antiviral properties, notably against the vaccinia virus. This compound is isolated from the marine-derived organism Ampulariella regularis, making it a valuable reagent for research in cancer therapeutics and virology.

Chlortetracycline is a calcium ionophore antibiotic that primarily targets bacterial protein synthesis by inhibiting the binding of aminoacyl-tRNA to ribosomes. This compound demonstrates potent bactericidal activity and serves as a selective inhibitor of methanogenic bacteria. Chlortetracycline is widely utilized in research applications involving antibiotic resistance studies and metabolic pathway investigations in anaerobic organisms.

Oritavancin diphosphate is a glycopeptide antibiotic that targets bacterial cell wall synthesis and inhibits ArlS kinase activity, thus disrupting signal transduction pathways. It exhibits potent bactericidal activity against gram-positive organisms, including Bacillus anthracis, with a minimum inhibitory concentration (MIC) of 0.015 µg/mL for the Ames strain. Oritavancin diphosphate is effective in various research applications related to antibiotic resistance and cell wall biochemistry, making it a valuable tool for microbiological studies.